sp-3164
salarius pharma
['lymphoma', 'sp-3164', 'hodgkin', 'salarius']
in our latest preclinical #cancerresearch, the novel molecular glue sp-3164 demonstrates potent antitumor activity in #nonhodgkinlymphomas. our very own aundrietta duncan can t wait to share the details at #eha2023! view the poster: 
Salarius is a cancer-focused biotechnology company. Currently in clinical trials for Ewing Sarcoma w/ Orphan Drug & Rare Pediatric Disease Designation.